Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes
| Autor: | John P. Fischer, Tess M. Lukowiak, Stephen J. Kovach, Jeremy R. Etzkorn, Cerrene N. Giordano, Christopher J. Miller, Leora Aizman, Stacy L. McMurray, Allison M. Perz, Raju R. Chelluri, Thuzar M. Shin, Joseph F. Sobanko, Thomas J. Guzzo, Aimee E. Krausz, Robert Caleb Kovell, H. William Higgins |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male medicine.medical_specialty Skin Neoplasms Urinary system Dermatology 030207 dermatology & venereal diseases 03 medical and health sciences Postoperative Complications 0302 clinical medicine Scrotum Humans Medicine Penile cancer Basal cell carcinoma Sex organ Patient Reported Outcome Measures Melanoma Penile Neoplasms Aged Retrospective Studies Aged 80 and over business.industry fungi Middle Aged Pennsylvania Mohs Surgery Urination Disorders medicine.disease Sexual Dysfunction Physiological Paget Disease Extramammary medicine.anatomical_structure Patient Satisfaction 030220 oncology & carcinogenesis Carcinoma Squamous Cell Genital Neoplasms Male Neoplasm Recurrence Local Skin cancer business Sexual function Carcinoma in Situ Penis |
| Zdroj: | Journal of the American Academy of Dermatology. 84:1030-1036 |
| ISSN: | 0190-9622 |
| Popis: | Background Local recurrence rates (LRRs) after Mohs micrographic surgery (MMS) for male genital cancers have been reported in only a few small case series, and patient-reported outcomes (PROs) have not been studied. Objective To determine the LRR and PROs after MMS for male genital skin cancers. Methods Retrospective review of all male genital skin cancers removed with MMS between 2008 and 2019 at an academic center. LRR was determined by chart review and phone calls. PROs were assessed by survey. Results A total of 119 skin cancers in 108 patients were removed with MMS. Tumors were located on the penis (90/119) and scrotum (29/119). Diagnoses included squamous cell carcinoma in situ (n = 71), invasive squamous cell carcinoma (n = 32), extramammary Paget disease (n = 13), melanoma (n = 2), and basal cell carcinoma (n = 1). The LRR was 0.84% (1/119), with a mean follow-up time of 3.25 years (median, 2.36 years). The majority of survey respondents reported no changes in urinary (66%) or sexual functioning (57.5%) after surgery. Limitations Retrospective single-center experience; short follow-up time; low survey response rate; no baseline functional data. Conclusion MMS for male genital skin cancer has a low LRR and high patient-reported satisfaction with urinary and sexual function. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect